Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 3Phase 1 3Phase NA 1Phase EARLY_PHASE1 1Phase 4 1

Status

Recruiting 3Completed 3

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 2Polycystic Ovary Syndrome 1Heart Failure 1

Interventions

Carboplatin 98Cisplatin 95pembrolizumab 90Gemcitabine 81Paclitaxel 80Docetaxel 73Capecitabine 64Oxaliplatin 53Specimen Handling 52Fluorouracil 52Magnetic Resonance Spectroscopy 50Bevacizumab 49Radiotherapy 48Dexamethasone 45Cyclophosphamide 44Leucovorin 39Drug Therapy 39Irinotecan 37Doxorubicin 36Pemetrexed 35Injections 30Trastuzumab 28Vincristine 27Rituximab 27Radiosurgery 25Prednisone 25Etoposide 25130-nm albumin-bound paclitaxel 25Radiation 24Letrozole 24

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Recruiting × dapagliflozin × Clear all
NCT06304857 2024-12-04

PROTECTAA

4th Military Clinical Hospital with Polyclinic, Poland

Phase 3 Recruiting
188 enrolled
Breast

Breast Neoplasms, Heart Failure

NCT06711185 2024-12-02

DAPA-MYOCANCER

University of Campinas, Brazil

Phase 3 Recruiting
80 enrolled
Breast

Breast Neoplasms

NCT06576375 2024-10-22

Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome

Future University in Egypt

Phase 3 Recruiting
70 enrolled

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡